ArticleEnvironmental science & technology2026

Do Chemically Modified Oligonucleotide Therapeutics Require Environmental Risk Assessment?

Thomas B Hofstetter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.